ICG dose and storage for lymph node mapping in gynecologic cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial looks at how the dose and storage of a dye called indocyanine green (ICG) affects its ability to find sentinel lymph nodes during surgery for gynecologic cancers like cervical, endometrial, and vulvar cancer. The goal is to make the procedure both more effective and more affordable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cervical, endometrial, or vulvar cancer.
- You are scheduled for surgery that uses indocyanine green dye to find sentinel lymph nodes.
- You are willing to have sentinel lymph node dissection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting a dye called indocyanine green (ICG) in different spots can better find sentinel lymph nodes during surgery for endometrial cancer. It may help doctors remove fewer nodes and reduce side effects.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
This trial uses a green dye to help surgeons see and remove lymph nodes during keyhole surgery for stomach cancer. The goal is to improve the accuracy of lymph node removal.
This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.
This trial tests if an injection of indocyanine green dye can help surgeons find and remove only the key lymph nodes in the armpit during breast cancer surgery. It aims to reduce the need for more extensive lymph node removal.
This trial tests a dye called ICG to find the first lymph nodes that might have cancer cells. It is for women with early-stage vulvar cancer that has not spread to the lymph nodes.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.